Elisa R. Port, MD, FACS, Named Chief of Breast Surgery at Mount Sinai School of Medicine
Renowned surgeon Elisa R. Port, MD, FACS, returns as Chief of Breast Surgery and Co-Director of the Dubin Breast Center.
Renowned surgeon Elisa R. Port, MD, FACS, is returning to The Mount Sinai Medical Center as Chief of Breast Surgery and Co-Director of the Dubin Breast Center. Her appointment becomes effective on April 26.
“The Dubin Center is a comprehensive, highly integrated program, and we wanted the best physicians in breast cancer clinical are and research to lead the team,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. “We’re pleased to have someone of Dr. Port’s caliber join our distinguished center.”
Dr. Port is a leading expert in sentinel-node biopsy, a procedure that allows physicians to determine the patient’s breast cancer stage, and the use of breast MRI in high-risk patients. Widely published on these topics and more, Dr. Port’s research has been featured in numerous journals, including the Journal of the American College of Surgeons, Annals of Surgery and Cancer Research.
Through a grant from the Susan G. Komen Foundation, Dr. Port researched positron emission tomography (PET), an imaging procedure that produces advanced 3-D images of the body, and its use in pre-operative assessment of breast cancer. She is also conducting, through funding from the National Cancer Institute, a Phase I study on the inhibition of the enzymes COX-2 and aromatase in breast cancer.
In addition to her research, Dr. Port is also a member of several professional associations, including the American Society of Clinical Oncology, the American Society of Breast Diseases, the Society of Surgical Oncology, and the American College of Surgeons, for whom she is a Fellow.
“Since graduating from Mount Sinai School of Medicine, Dr. Port has conducted seminal research on breast cancer and remained committed to seamless patient care,” said Michael L. Marin, M.D., F.A.C.S., The Julius H. Jacobson II, M.D. Professor of Surgery, and Chairman, Department of Surgery, Mount Sinai School of Medicine.“With Dr. Port at the helm, Mount Sinai will further solidify its reputation of providing top-rated breast cancer care.”
After receiving her medical degree from Mount Sinai School of Medicine in 1992, Dr. Port was a general surgery resident at Cedars-Sinai Medical Center in Los Angeles until 1994. She then joined Memorial Sloan-Kettering Cancer Center for a breast cancer surgery research fellowship, and then continued on to Long Island Jewish Medical Center where she had completed a general surgery residency. In 1999 she joined Memorial Sloan-Kettering Cancer Center and Memorial Hospital for Cancer and Allied Diseases, where she remained as an Associate Member and Associate Attending Surgeon until her Mount Sinai appointment.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 60,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants. For more information, please visit www.mountsinai.org.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.